GCG and Obesity: Additionally, it has been found that probiotics and SCFAs administration, as part of anti-obesity and diabetes interventions, could involve the modification of microbiota, the upregulation of GLP-1 production and related SCFAs, such as acetate, and increasing fasting fat oxidation and resting energy expenditure (53–55).